- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Pharma Execs Outline Cautious Playbook for Agentic AI
Leaders agree on starting narrow, building guardrails, and closely monitoring AI adoption in regulated industries.
Mar. 19, 2026 at 3:03pm
Got story updates? Submit your updates here. ›
Pharma executives gathered at a USEReady-hosted event in New Jersey to discuss their approach to adopting agentic AI. The consensus was to start with tightly scoped use cases, build clear governance and observability structures into agent design, and plan for a multi-year monitoring program - a measured approach reflecting the high stakes of AI in regulated, patient-facing industries.
Why it matters
As AI agents become more autonomous, pharma companies are grappling with how to responsibly implement the technology while navigating complex data, governance, and reliability challenges. This executive discussion provides a window into how leading organizations are tackling these issues and establishing principles for ethical, trustworthy AI adoption.
The details
The session, part of USEReady's Breakfast with Agents series, drew senior leaders from R&D, Clinical Operations, Commercial & Medical Affairs, Supply Chain, and Digital functions across the Life Sciences industry. Spanning use cases like Go-to-Market Strategy, Brand Performance Monitoring, Market Research, Global Forecasting, Marketing Mix Modeling, and Content Personalization, the discussion revealed where AI agents are already delivering value and where the hard work of enterprise implementation is only beginning.
- The executive gathering took place recently at The Westin Princeton in New Jersey.
- USEReady's next Breakfast with Agents event is scheduled for April 2 in Dallas.
The players
Uday Hegde
Co-founder & CEO, USEReady
Priya Raghupathi
Industry Advisor and Senior Pharma Transformation Leader who led the session
USEReady
A company that empowers enterprises with AI and data analytics solutions to drive intelligent, autonomous transformation.
What they’re saying
“Pharma is not slow to adopt AI – it is slow to adopt AI carelessly, which is exactly the right instinct.”
— Uday Hegde, Co-founder & CEO, USEReady
“What struck me most was the honesty in that room. These are leaders who are actively in the middle of implementation decisions, not evaluating AI from a distance. The conversation wasn't about potential – it was about how to get it right. That's a meaningful shift from where these discussions were even a year ago.”
— Priya Raghupathi, Industry Advisor and Senior Pharma Transformation Leader
What’s next
USEReady's next Breakfast with Agents gathering moves to Dallas on April 2, where the lens shifts to Energy, Manufacturing, and Engineering Services industries.
The takeaway
Pharma companies are taking a cautious, measured approach to adopting agentic AI, focusing on starting narrow, building robust governance structures, and closely monitoring the technology's impact over multiple years - an approach that reflects the high stakes and complex challenges of implementing autonomous systems in regulated, patient-facing industries.
